CHANGES IN ULTRASONOGRAPHIC VASCULARITY UPON INITIATION OF ADALIMUMAB COMBINATION THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Kaeley, G. S. [1 ]
Nishio, M. J. [2 ]
Goyal, J. R. [3 ]
MacCarter, D. K. [4 ]
Wells, A. F. [5 ]
Cardoso, A. [6 ]
Chen, S. [7 ]
Kalabic, J. [8 ]
Kupper, H. [8 ]
机构：
[1] Univ Florida, Coll Med, Jacksonville, FL USA
[2] Diablo Clin Res, Walnut Creek, CA USA
[3] Raritan Bay Med Ctr, Perth Amboy, NJ USA
[4] DK MacCarter Coeur dAlene Arthrit Clin, Coeur Dalene, ID USA
[5] Rheumatol & Immunotherapy Ctr, Franklin, TN USA
[6] AbbVie Inc, Lisbon, Portugal
[7] AbbVie Inc, N Chicago, IL USA
[8] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0238
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [21] Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study
    Taylor, Peter C.
    Keystone, Edward C.
    van der Heijde, D.
    Tanaka, Yoshiya
    Ishii, Taeko
    Emoto, Kahaku
    Yang, Lili
    Arora, Vipin
    Gaich, Carol L.
    Rooney, Terence
    Schlichting, Douglas E.
    Macias, William
    de Bono, Stephanie
    Weinblatt, Michael E.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Baricitinib vs. placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study
    Taylor, P.
    Keystone, E. C.
    van der Heijde, D.
    Tanaka, Y.
    Ishii, T.
    Emoto, K.
    Yang, L.
    Arora, V.
    Gaich, C.
    Rooney, T.
    Schlichting, D.
    Macias, W. L.
    De Bono, S.
    Weinblatt, M. E.
    Larsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 8 - 8
  • [23] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon, J. Abraham
    Baraf, Herbert S. B.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Genovese, Mark C.
    Mozaffarian, Neelufar
    Landewe, Robert B. M.
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
  • [24] The combination glucocorticoid-adalimumab-methotrexate as induction therapy in early aggressive rheumatoid arthritis
    Montecucco, Carlomaurizio
    Caporali, Roberto
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
  • [25] EFFICACY AND SAFETY OF ADALIMUMAB WITH LOW AND HIGH DOSE-METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: THE RANDOMISED CONTROLLED MIRACLE STUDY
    Tamai, H.
    Ikeda, K.
    Miyamoto, T.
    Taguchi, H.
    Kuo, C. F.
    Shin, K.
    Hirata, S.
    Okano, Y.
    Sato, S.
    Yasuoka, H.
    Choi, I. A.
    Park, S. H.
    Weng, M. Y.
    Kuwana, M.
    Lee, Y. J.
    Ishii, T.
    Kim, J.
    Kameda, H.
    Kojima, T.
    Baek, H. J.
    Hsu, P. N.
    Huang, C. M.
    Cheng, T. T.
    Sung, W. Y.
    Taninaga, T.
    Mori, M.
    Miyagishi, H.
    Sato, Y.
    Takeuchi, T.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 42 - 43
  • [26] Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    van Riel, P. L. C. M.
    Taggart, A. J.
    Sany, J.
    Gaubitz, M.
    Nab, H. W.
    Pedersen, R.
    Freundlich, B.
    MacPeek, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1478 - 1483
  • [27] Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
    Mroczkowski, PJ
    Weinblatt, ME
    Kremer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S66 - S68
  • [28] COMBINATION METHOTREXATE AND SULFASALAZINE THERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    MORAND, EF
    AXTENS, RSK
    LITTLEJOHN, GO
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S53 - S53
  • [29] Adalimumab and Methotrexate Pharmacokinetics Following Combination Therapy With Different Methotrexate Doses in Methotrexate and Biologic-Naive Rheumatoid Arthritis Patients: Concerto Study
    Goss, Sandra L.
    Klein, Cheri E.
    Kupper, Hartmut
    Burmester, Gerd R.
    Awni, Walid
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S212 - S212
  • [30] Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab
    Smolen, Josef S.
    Bu, Xianwei
    Wang, Xin
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345